Cardinal Health, Inc. (NYSE:CAH) Short Interest Down 22.2% in December

Cardinal Health, Inc. (NYSE:CAH) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling 4,904,967 shares, a decline of 22.2% from the November 30th total of 6,300,853 shares. Based on an average daily volume of 2,521,603 shares, the short-interest ratio is presently 1.9 days. Approximately 2.1% of the shares of the company are short sold. Approximately 2.1% of the shares of the company are short sold. Based on an average daily volume of 2,521,603 shares, the short-interest ratio is presently 1.9 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. SJS Investment Consulting Inc. raised its position in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC increased its stake in shares of Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares in the last quarter. JPL Wealth Management LLC bought a new position in shares of Cardinal Health in the third quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in Cardinal Health during the 3rd quarter worth about $31,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of Cardinal Health stock traded down $0.06 during trading on Tuesday, hitting $207.33. 1,205,802 shares of the company’s stock traded hands, compared to its average volume of 2,402,944. The company has a market cap of $49.26 billion, a PE ratio of 31.27, a PEG ratio of 1.52 and a beta of 0.63. The firm’s fifty day moving average price is $197.29 and its 200 day moving average price is $170.59. Cardinal Health has a twelve month low of $117.53 and a twelve month high of $214.93.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the previous year, the firm earned $1.88 EPS. Cardinal Health’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio is currently 30.77%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CAH shares. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Robert W. Baird set a $232.00 price target on shares of Cardinal Health in a research report on Friday, October 31st. Wells Fargo & Company upped their price objective on shares of Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Leerink Partners increased their target price on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $209.00.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.